SCHEMBL5166418

SCHEMBL5166418

CN(C)C1(c2ccccc2)CCC(NCCc2c[nH]c3cc(F)ccc23)CC1

nearest known ligand 0.85

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
OPRL1 P41146 12/20 0.85
OPRM1 P35372 11/20 0.85
ACHE P22303 2/20 0.49
MEN1 O00255 1/20 0.46
ALDH1A1 P00352 1/20 0.46
MAPK1 P28482 1/20 0.46
KMT2A Q03164 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HTR1A P08908 1/20 0.44
VCP P55072 1/20 0.44
HTR2A P28223 1/20 0.43
HTR6 P50406 1/20 0.42
BCHE P06276 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL5167221 0.99 OPRL1 (0.86) OPRL1OPRM1ACHEMEN1ALDH1A1
SCHEMBL5163332 0.92 OPRL1 (1.00) OPRL1OPRM1
Hydrochloric Acid SCHEMBL5164886 0.91 OPRL1 (1.00) OPRL1OPRM1HTR2A
SCHEMBL5163716 0.88 OPRL1 (1.00) OPRL1OPRM1MEN1ALDH1A1MAPK1
Hydrochloric Acid SCHEMBL5165408 0.87 OPRL1 (1.00) OPRL1OPRM1MEN1ALDH1A1MAPK1
SCHEMBL5166857 0.83 OPRL1 (0.80) OPRL1OPRM1MEN1ALDH1A1MAPK1
Hydrochloric Acid SCHEMBL5164725 0.82 OPRL1 (0.81) OPRL1OPRM1MEN1ALDH1A1MAPK1
SCHEMBL5164757 0.82 OPRL1 (0.79) OPRL1OPRM1ACHEMEN1ALDH1A1
Hydrochloric Acid SCHEMBL5167045 0.82 OPRL1 (0.79) OPRL1OPRM1ACHEMEN1ALDH1A1
Hydrochloric Acid SCHEMBL27606524 0.81 OPRL1 (0.60) OPRL1OPRM1ACHEHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1392641-B1 SUBSTITUTED CYCLOHEXANE-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2007-04-11 EP claimed
US-7276518-B2 Substituted cyclohexane-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2007-10-02 US disclosed
EP-1392641-B1 SUBSTITUTED CYCLOHEXANE-1,4-DIAMINE DERIVATIVES GRUENENTHAL GMBH (DE) 2007-04-11 EP disclosed
US-20040229872-A1 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity GRUENENTHAL GMBH (DE) 2004-11-18 US disclosed
US-20040162287-A1 Substituted cyclohexane-1,4-diamine compounds GRUENENTHAL GMBH (DE) 2004-08-19 US disclosed
EP-1392641-A1 SUBSTITUTED CYCLOHEXANE-1,4-DIAMINE DERIVATIVES Grünenthal GmbH (DE) 2004-03-03 EP disclosed
EP-1385493-A1 SUBSTITUTED CYCLOHEXAN-1,4-DIAMINE DERIVATIVES WITH CONSTIPATING AND PERIPHERAL ANALGESIC PROPERTIES Grünenthal GmbH (DE) 2004-02-04 EP disclosed
WO-2002090317-A1 SUBSTITUTED CYCLOHEXANE-1,4-DIAMINE DERIVATIVES Grünenthal GmbH (DE) 2002-11-14 WO disclosed
WO-2002089783-A1 SUBSTITUTED CYCLOHEXAN-1,4-DIAMINE DERIVATIVES WITH CONSTIPATING AND PERIPHERAL ANALGESIC PROPERTIES Grünenthal GmbH (DE) 2002-11-14 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040162287-A1 Substituted cyclohexane-1,4-diamine compounds DPYD, DDC, QDPR OPRL1 1102/4885OPRM1 459/4885ACHE 952/4885
US-20040229872-A1 Substituted cyclohexane-1,4-diamine compounds with anti-diarrhea and peripheral analgesic activity ARG1, CD2, PDCD1 OPRL1 41/4885OPRM1 250/4885ACHE 186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.